Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 2/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 10/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL397472 | 0.87 | USP2 (0.58) | USP2ALDH1A1MEN1KMT2APOLB | |
| SCHEMBL11774581 | 0.84 | USP2 (0.62) | USP2L3MBTL1ALDH1A1MEN1KMT2A | |
| SCHEMBL5567042 | 0.80 | ALDH1A1 (0.75) | L3MBTL1ALDH1A1MEN1KMT2ALMNA | |
| SCHEMBL394836 | 0.80 | ALDH1A1 (0.57) | L3MBTL1ALDH1A1POLBLMNA | |
| SCHEMBL9568540 | 0.79 | USP2 (0.57) | USP2L3MBTL1ALDH1A1MEN1KMT2A | |
| SCHEMBL15145851 | 0.79 | ALDH1A1 (0.71) | USP2L3MBTL1ALDH1A1MEN1KMT2A | |
| SCHEMBL8213969 | 0.79 | ALDH1A1 (0.72) | L3MBTL1ALDH1A1MEN1KMT2ALMNA | |
| SCHEMBL28486057 | 0.78 | LMNA (0.77) | L3MBTL1ALDH1A1MEN1KMT2APOLB | |
| SCHEMBL195196 | 0.78 | LMNA (0.56) | ALDH1A1KMT2APOLBLMNANPSR1 | |
| SCHEMBL14521460 | 0.78 | USP2 (0.58) | USP2L3MBTL1ALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5141838-A | Lithography printing plates | FUJI PHOTO FILM CO., LTD. (JP) | 1992-08-25 | — | — | US | claimed |
| US-20120146264-A1 | RESIN COMPOSITION FOR LASER ENGRAVING, RELIEF PRINTING PLATE PRECURSOR FOR LASER ENGRAVING AND PROCESS FOR PRODUCING SAME, AND PROCESS FOR MAKING RELIEF PRINTING PLATE | FUJIFILM CORPORATION (JP) | 2012-06-14 | — | — | US | disclosed |
| US-8101332-B2 | Negative-working lithographic printing plate precursor and method of lithographic printing using same | FUJIFILM CORPORATION (JP) | 2012-01-24 | — | — | US | disclosed |
| EP-1972440-B1 | Negative lithographic printing plate precursor and lithographic printing method using the same | FUJIFILM CORP (JP) | 2010-06-23 | — | — | EP | disclosed |
| EP-1136886-B1 | Positive-working presensitized plate useful for preparing a lithographic printing plate | FUJIFILM CORP (JP) | 2010-05-19 | — | — | EP | disclosed |
| US-20090246688-A1 | NEGATIVE-WORKING LITHOGRAPHIC PRINTING PLATE PRECURSOR AND METHOD OF LITHOGRAPHIC PRINTING USING SAME | FUJIFILM CORPORATION (JP) | 2009-10-01 | — | — | US | disclosed |
| EP-2105298-A1 | Negative-working lithographic printing plate precursor and method of lithographic printing using same | Fujifilm Corporation (JP) | 2009-09-30 | — | — | EP | disclosed |
| US-20080233516-A1 | NEGATIVE LITHOGRAPHIC PRINTING PLATE PRECURSOR AND LITHOGRAPHIC PRINTING METHOD USING THE SAME | FUJIFILM CORPORATION (JP) | 2008-09-25 | — | — | US | disclosed |
| EP-1972440-A2 | Negative lithographic printing plate precursor and lithographic printing method using the same | FUJIFILM Corporation (JP) | 2008-09-24 | — | — | EP | disclosed |
| CN-1235089-C | Photosensitive lithographic printing plate | FUJI PHOTO FILM CO LTD (JP) | 2006-01-04 | — | — | CN | disclosed |
| US-6517987-B2 | Mixture of 1,2-naphthoquinone-2-diazide-5-sulfonic acid and polymer | FUJI PHOTO FILM CO., LTD. (JP) | 2003-02-11 | — | — | US | disclosed |
| CN-1355448-A | Photosensitive lithographic printing plate | FUJI PHOTO FILM CO LTD (JP) | 2002-06-26 | — | — | CN | disclosed |
| EP-0671660-B1 | Lead-frame forming material | FUJI PHOTO FILM CO LTD (JP) | 2001-10-17 | — | — | EP | disclosed |
| EP-1136886-A1 | Positive-working presensitized plate useful for preparing a lithographic printing plate | Fuji Photo Film Co., Ltd. (JP) | 2001-09-26 | — | — | EP | disclosed |
| EP-1077392-A1 | Photosensitive lithographic printing plate | FUJI PHOTO FILM CO., LTD. (JP) | 2001-02-21 | — | — | EP | disclosed |
| US-5670293-A | LIGHT SENSITIVE MATERIAL WITH COPPER OR NICKEL ALLOYS, DRYING A PHOTOSENSITIVE LAYER AND WINDING THE COATED WEB INTO STRIPS AND STACKING | FUJI PHOTO FILM CO., LTD. (JP) | 1997-09-23 | — | — | US | disclosed |
| EP-0330239-B1 | Photosensitive composition | FUJI PHOTO FILM CO LTD (JP) | 1996-05-22 | — | — | EP | disclosed |
| EP-0671660-A2 | Lead-frame forming material | FUJI PHOTO FILM CO., LTD. (JP) | 1995-09-13 | — | — | EP | disclosed |
| US-5141838-A | Lithography printing plates | FUJI PHOTO FILM CO., LTD. (JP) | 1992-08-25 | — | — | US | disclosed |
| EP-0330239-A2 | Photosensitive composition | FUJI PHOTO FILM CO., LTD. (JP) | 1989-08-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120146264-A1 | RESIN COMPOSITION FOR LASER ENGRAVING, RELIEF PRINTING PLATE PRECURSOR FOR LASER ENGRAVING AND PROCESS FOR PRODUCING SAME, AND PROCESS FOR MAKING RELIEF PRINTING PLATE | EIF3L, EIF2B1, EIF2B5 | USP2 2055/4885L3MBTL1 1189/4885ALDH1A1 1302/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.